Navigation Links
Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics
Date:10/1/2009

Reston, Va.SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19󈞁, 2009. The joint session, co-hosted by SNM and CMOD, will be held on Wednesday, Oct. 21, from 12:30 p.m. to 4:15 p.m.

"We are pleased to further extend our collaboration with the International Partnership for Critical Markers of Disease by holding this joint session on molecular imaging biomarkers in clinical research," said Michael Graham, PhD, MD, SNM president and director of nuclear medicine at the University of Iowa Carver College of Medicine. "We have established a vital scientific partnership to promote the expanded use and validation of molecular imaging biomarkers for clinical trials. Improved availability and performance of molecular imaging biomarkers will facilitate the development of safe and effective therapeutic drugs and ultimately enhance the delivery of personalized medicine."

"Our common interest in accelerating scientific research and therapeutic drug development by creating novel and advanced biomarkers to promote optimal health care today is a model for others to follow," said Therese Heinonen, DVM, executive director and co-founder of the International Partnership for Critical Markers of Disease and associate director of scientific affairs, Montreal Heart Institute Coordinating Center. "SNM and CMOD share the vision of expanding the use of these biomarkers in a standardized clinical research environment where providing high-quality, cost-effective patient care is the ultimate goal."

Peter Libby (co-founder of CMOD and Mallinckrodt Professor of Medicine at Harvard Medical School and chief of cardiovascular medicine at Brigham and Women's Hospital) will moderate the special afternoon session with Michael Graham. Don Black, general manager of molecular imaging at GE Healthcare's Medical Diagnostics, and Alexander J.B. McEwan, MD, chair of the department of oncology at the University of Alberta, Canada, will present perspectives on standardizing molecular imaging clinical trials, with an emphasis on the challenges of developing molecular imaging agents and statistical considerations in trial design. The second panel, led by Dan Skovronsky, founder and CEO of Avid Pharmaceuticals, and Patricia Cole, executive director of Imagepace at Medpace, Inc., will discuss the potential role of molecular imaging biomarkers in therapeutic development in both oncology and neurologytwo areas of significant interest to clinicians, researchers and industry. The session concludes with presentations focused on challenges and opportunities for using molecular imaging biomarkers in clinical research.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting
2. 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition
3. American Society of Plastic Surgeons hosts 78th annual meeting
4. American Society Of Plastic Surgeons Hosts 78th Annual Meeting
5. American Heart Association Meeting Report: High-Sugar Diet Increases Mens Blood Pressure; Gout Drug Protective
6. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
7. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
8. SpectraScience Announces Results of Annual Shareholder Meeting
9. Maternal/child health focus of African Science Academies meeting in Ghana Nov. 9-11
10. Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting
11. Dean MacCarter, Ph.D. Addressed Differentiation of Responder vs Non-Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article ... for colds or respiratory issues that are not responsive to antibiotics nevertheless obtain prescriptions ... may be largely responsible for the problem both in Canada and the United States. ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to ... campaign in USA Today, which will educate readers on how to take care of ... a large focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). ... interface for diagnostic device operations. With this platform, initializing devices and importing studies ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on ... will continue to be available at a discounted crowdfunding price on Indiegogo . ... they are, I also wanted to bring a fidget toy to the market that ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a ... creation of published author Laura Weigel Douglas, an avid reader who lives in the ... that sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... , May 25, 2017  In response to ... , Direct Relief is working with Pfizer to ... available at no cost to community health centers, free ... providers nationwide. "Pfizer has a long-standing ... medicines and ensuring patient safety through educational activities," said ...
(Date:5/18/2017)... 2017  Two Bayer U.S. Pharmaceutical leaders received top ... recent 28 th Woman of the Year ... HBA,s longstanding mission of furthering the advancement and impact ... Cindy Powell-Steffen , senior director of brand activation ... Libby Howe , a regional business manager for ...
(Date:5/11/2017)... May 11, 2017  Thornhill Research Inc. ( ... awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract ... Canadian Commercial Corporation (CCC) ( Ottawa, Ontario, ... to administer general anesthesia to patients requiring emergency ... "The US Marine Corps have been a longtime ...
Breaking Medicine Technology: